- Home
- GRABW vs BCTXZ Comparison
GRABW vs BCTXZ Comparison
Compare GRABW & BCTXZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- BCTXZ
- Stock Information
- Founded
- GRABW 2012
- BCTXZ N/A
- Country
- GRABW Singapore
- BCTXZ Canada
- Employees
- GRABW 11267
- BCTXZ 12
- Industry
- GRABW Business Services
- BCTXZ
- Sector
- GRABW Consumer Discretionary
- BCTXZ
- Exchange
- GRABW Nasdaq
- BCTXZ Nasdaq
- Market Cap
- GRABW N/A
- BCTXZ N/A
- IPO Year
- GRABW N/A
- BCTXZ N/A
- Fundamental
- Price
- GRABW $0.39
- BCTXZ $1.02
- Analyst Decision
- GRABW
- BCTXZ
- Analyst Count
- GRABW 0
- BCTXZ 0
- Target Price
- GRABW N/A
- BCTXZ N/A
- AVG Volume (30 Days)
- GRABW 54.7K
- BCTXZ N/A
- Earning Date
- GRABW 02-21-2025
- BCTXZ N/A
- Dividend Yield
- GRABW N/A
- BCTXZ N/A
- EPS Growth
- GRABW N/A
- BCTXZ N/A
- EPS
- GRABW N/A
- BCTXZ N/A
- Revenue
- GRABW $2,686,000,000.00
- BCTXZ N/A
- Revenue This Year
- GRABW N/A
- BCTXZ N/A
- Revenue Next Year
- GRABW N/A
- BCTXZ N/A
- P/E Ratio
- GRABW N/A
- BCTXZ N/A
- Revenue Growth
- GRABW 21.65
- BCTXZ N/A
- 52 Week Low
- GRABW $0.15
- BCTXZ N/A
- 52 Week High
- GRABW $0.59
- BCTXZ N/A
- Technical
- Relative Strength Index (RSI)
- GRABW 44.66
- BCTXZ N/A
- Support Level
- GRABW $0.40
- BCTXZ N/A
- Resistance Level
- GRABW $0.45
- BCTXZ N/A
- Average True Range (ATR)
- GRABW 0.05
- BCTXZ 0.00
- MACD
- GRABW -0.01
- BCTXZ 0.00
- Stochastic Oscillator
- GRABW 6.14
- BCTXZ 0.00
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About BCTXZ BriaCell Therapeutics Corp. Warrant
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.